Two babies in Kentucky have lost their lives to pertussis, also known as whooping cough, as recently reported by the Kentucky Department for Public Health. These deaths, the first pertussis-related since 2018, have refocused attention on a resurging danger once thought largely brought under control in America- vaccine-preventable illnesses.

With over 10,000 cases reported across the country in the first six months of 2025, close to twice as many as the same six months a year ago public health officials are warning an alarm. The epidemic, which tracks with trends in other diseases like measles, coincides with declining childhood vaccination rates, anti-vaccination sentiment, and pandemic-period interruptions of routine vaccination activities.

Whooping cough is a very contagious respiratory infection that is brought on by the bacterium Bordetella pertussis, originally described in 1906 by French scientists. Nevertheless, centuries ago, there were mentions of the illness—its earliest probable epidemic was seen in Paris in 1578.

The disease is notorious for its intense, hacking cough that is followed by a piercingly high-pitched "whoop" upon inhalation. In newborns, particularly those too young to be vaccinated, pertussis may cause lethal complications such as pneumonia, seizures, and respiratory distress. Some doctors call it "the 100-day cough" because its duration lasts for many weeks or even months.

According to the World Health Organization, pertussis still causes approximately 160,700 deaths annually in children under the age of five worldwide, a statistic that highlights the ongoing global burden of the disease, especially in settings with limited vaccine coverage.

The two infants who perished in Kentucky in the last six months were not vaccinated, and neither were their mothers while pregnant. These events highlight a key gap in protection that maternal vaccination seeks to close. Babies under 6 weeks are too young to get their first dose of pertussis vaccine, and so remain extremely exposed early in life.

Third-trimester maternal immunization allows for the passing on of protective antibodies to the newborn, protecting them until they are of age to start their own vaccine regimen. Without the added layer of protection, there is a marked increase in risk of severe illness or mortality.

Through June 2025, the U.S. has reported a minimum of 8,485 confirmed cases of pertussis, already passing the 4,266 cases reported for the same period in 2024. For 2024, as reported by the CDC, a combined total of 35,435 cases were reported—more than five times that of 2023 and close to twice that of 2019, the final year before the pandemic.

Kentucky alone has reported 247 cases of pertussis through 2025, after reporting 543 cases in 2024—the largest number in the state since 2012. Across the country, from October 2024 through April 2025, four deaths from pertussis have been reported: two infants, one school-age child, and one adult.

Why Are Whooping Cough Cases Increasing Again?

The return of pertussis in the United States is being fueled by a mix of related factors. One major cause is the cyclical pattern of the disease, since pertussis has epidemic patterns with episodes peaking every two to five years. Although such peaks are anticipated, experts note that the current peak is more severe compared to what is normally seen during normal peaks. Post-pandemic immunity gap is also a crucial factor. Throughout the COVID-19 pandemic that occurred during 2020 and 2022, pertussis rates decreased significantly because of widespread public health interventions like masking, physical distancing, and closing schools. Since those measures are no longer in effect, numerous persons including children who were left unvaccinated or were missed during their periodic vaccinations since then are now at increased risk for infection. Adding to this problem is the decrease in vaccination coverage, driven by increased misinformation, increased skepticism about the vaccine, and interruptions in access to health care. That decline in immunization, especially in infants and pregnant women, is one of the most urgent priorities driving the national epidemic of pertussis.

How Effective Are Vaccines Against Pertussis?

The pertussis vaccine itself has changed dramatically over the years since it was first introduced in the U.S. in 1914.

Today's acellular form—DTaP for infants and children and Tdap for teens and adults—was introduced in the 1990s as a way to reduce side effects like seizures and high fevers that were caused by the older whole-cell vaccine. Although the acellular vaccine offers robust protection initially, the immunity fades with time. During the first year after completion of the five-dose course of childhood pertussis vaccination, some 98% of children are protected against pertussis.

By the fifth year after the last dose, however, that immunity declines to roughly 65%. This drop highlights the necessity of booster shots in young adulthood and adolescence to ensure sustained protection. While immunity from the current vaccine is not long-term, it still represents the best weapon against severe disease, complications, and mortality. The unvaccinated are 13 times more likely to develop pertussis compared to their vaccinated counterparts, and they have much greater risks of being hospitalized or killed by the disease.

Who Should Be Vaccinated, and When?

The CDC and other top public health organizations suggest:

Infants: Shots at 2, 4, and 6 months, with boosters at 15 months and 4 years.

Adolescents: A Tdap booster dose at 11 or 12 years.

Adults: One Tdap booster in adulthood, with re-vaccination every 10 years.

Pregnant Women: One dose of Tdap between weeks 27–36 of every pregnancy to confer immunity to the newborn through passive antibody transfer.

Local health departments might even suggest extra boosters for people who reside in outbreak-facilitating areas particularly on the West Coast, where states such as California, Washington, and Oregon have seen high case totals this year.

How Can You Protect Yourself and Your Family?

The increase in pertussis cases—and its disastrous effect on babies—underscores the necessity of public education, uniform messaging by health workers, and availability of immunization services. Parents and caregivers should be motivated to keep their own and children's vaccination schedules up to date, especially in communities where disease outbreaks are reported.

Clinicians have a key role in advising maternal immunization and informing families about the signs of whooping cough, which is likely to be confused with the common cold at its initial onset.

Are you in awe of weight loss injections? Well, here is some news. They might be doing more than just helping you lose fat. According to a new study, the same drugs that are helping people drop kilos might also be calming their lungs, specifically in people who are both obese and asthmatic.

If you have heard of Ozempic or Mounjaro, you probably know they are part of a growing class of drugs originally designed for people with type 2 diabetes. These are called GLP-1 receptor agonists (GLP1-RAs), and they work by mimicking a gut hormone that controls blood sugar and, conveniently, appetite. What is new, though, is their potential to help with another major issue, breathing.

The Link Between Asthma and Obesity

According to the American Lung Association, people with a BMI of 30 or higher are much more likely to have asthma. It is not just because the extra weight makes it harder to breathe. Fat tissue itself releases inflammatory chemicals that can mess with lung function.

Meanwhile, asthma can make physical activity feel like a battle, and long-term steroid use can ramp up hunger, meaning it is all too easy to get stuck in a cycle where obesity and asthma fuel each other.

The Study: What They Found

Published in the journal Advances in Therapy, the study looked at health records from over 60,000 people. One group of 10,111 were prescribed GLP1-RAs, while the rest were not.

After a follow-up, the group on the jabs had lost more weight, but they also had better control over their asthma. And the average weight loss was just 0.9 kg over the year. So it was not just about shedding pounds. Something else was clearly at play.

Reportedly, GLP1s work on inflammatory responses in the airways in a different way to traditionally used steroids. In other words, the drug may be doing a direct job on the lungs, not just helping from the sidelines by shrinking waistlines.

Experts Weigh In

Prof Alan Kaplan, chairperson of the Family Physician Airways Group of Canada and the Observational and Pragmatic Research Institute, told The Sun: "Our findings suggest that GLP1-RAs have benefits on asthma control in people with obesity, and this information should contribute to the discussions around the decision to use these drugs."

Dr Erika Kennington from Asthma and Lung UK told the publication that this could be promising for people who feel stuck. "Although exercise can help people lose weight, for some people it can cause anxiety about becoming breathless or having an asthma attack, so people are stuck in a vicious cycle of not being able to lose weight and their asthma worsening."

However, she also sounded a note of caution. "Therefore, where exercise hasn't worked for someone these drugs that support weight loss could offer a promising alternative.

"It's too early to say whether these drugs would be effective for people with asthma more widely.

"More research is needed to understand how these drugs actually improve asthma control. Funding for lung health research is on life support, and urgent action is needed to increase investment."

A Possible Turning Point for Millions

Millions of people in the UK are living with asthma. At the same time, nearly two-thirds of adults in England are overweight or obese. For people stuck between breathlessness and weight gain, these jabs could be a literal breath of fresh air. Still, while the findings are exciting, no one is saying these jabs are a magic fix for everyone with asthma.

Hulk Hogan, the wrestling legend has passed away at the age of 71, according to a report by TMZ Sports. Emergency services were reportedly dispatched to his Florida residence following a 911 call for a suspected cardiac arrest.

TMZ also reported that a video outside Hogan's residence show that the responders had tried to desperately save him while he was being transported to an ambulance. The clip shows that several paramedics were, what it seems like, conducting compression as Hogan was being wheeled to the emergency vehicle.

Hogan's death comes just weeks after his wife publicly denied rumors that the WWE Hall of Famer was in a coma, reassuring fans that his heart was “strong” and that he was recovering well after multiple surgeries.

Widely credited with transforming professional wrestling into a mainstream global phenomenon, Hogan—born Terry Bollea—was more than just a wrestler. With his signature bandana, handlebar mustache, and larger-than-life personality, he became a household name in the 1980s and 1990s, helping to usher in an era when wrestling became part of pop culture.

What Happens During Cardiac Arrest?

Jonathan Chrispin, MD, from John Hopkins Medicine, writes, that a cardiac arrest, also known as a sudden cardiac arrest, in when the heart stops beating suddenly. The lack of blood flow to the brain and other organ can cause a person to lose consciousness, become disabled or die if not treated immediately.

Is cardiac arrest the same as a heart attack? The answer is no, as per the Heart Organization, a heart attack occurs when blood flow to the heart is blocked, whereas in a cardiac arrest, heart suddenly stops beating.

What Are The Symptoms Of A Cardiac Arrest?

In some cases of cardiac arrest, there may be no symptoms at all. You may experience these symptoms prior to cardiac arrest:

• Fatigue
• Dizziness
• Shortness of breath
• Nausea
• Chest pain
• Heart palpitations (fast or pounding heart beat)
• Loss of consciousness

What Causes A Cardiac Arrest?

Common Causes of Cardiac Arrest:

Arrhythmia and Ventricular Fibrillation

Arrhythmia refers to an irregular heartbeat caused by disrupted electrical signals in the heart. One of the most dangerous types is ventricular fibrillation—a rapid, chaotic heartbeat in the ventricles. Instead of pumping blood effectively, the heart quivers, leading to sudden cardiac arrest.

Enlarged Heart (Cardiomyopathy)

Cardiomyopathy occurs when the heart muscle becomes enlarged—either dilated or thickened—resulting in weak or abnormal heart contractions. This condition increases the risk of heart failure and cardiac arrest.

Coronary Artery Disease (CAD)

CAD is caused by plaque buildup that narrows and hardens the coronary arteries, restricting blood flow to the heart. If untreated, it can lead to arrhythmias or heart failure—both of which can trigger cardiac arrest.

Other Potential Causes of Cardiac Arrest

• Severe blood loss
• Valvular heart disease (damage or defects in the heart valves)
• Lack of oxygen (such as from drowning or choking)
• Electrolyte imbalances, particularly high levels of potassium or magnesium, which can disrupt heart rhythm and lead to arrhythmia

Early diagnosis and timely medical intervention are critical in preventing these conditions from progressing to cardiac arrest.

Teddi Mellencamp Cancer Update: Reality TV star and podcast host Teddi Mellencamp has revealed she is pausing her immunotherapy treatment as part of her ongoing battle with stage 4 cancer.

In an update during the July 24 episode of her podcast Two T’s in a Pod, Mellencamp shared that her body has been struggling to cope with the effects of the aggressive treatment, despite promising results in shrinking tumors.

The 44-year-old former Real Housewives of Beverly Hills cast member detailed that she had not been feeling well for nearly a month and had grown increasingly fatigued and disoriented. “It was kind of shocking to me, and I think mentally it did a lot to me,” she said. “I started asking myself, ‘Why do I feel like I can barely open my eyes or keep my words straight?’”

After undergoing emergency scans and consulting her doctors, Mellencamp was told that the sickness she was feeling wasn’t from the cancer itself, but from the very treatment designed to help her.

Immunotherapy on Hold for Now

Immunotherapy, a treatment that harnesses the body's immune system to fight cancer, has shown signs of success in Mellencamp’s case. Doctors confirmed that the tumors in her lungs and brain were shrinking. “They did a bunch of scans and everything’s looking good, everything’s shrinking,” she said on the podcast.

However, the toll on her body has forced a critical decision, take a break to recover strength.

“So we’re going to take a little break on the immunotherapy to get my body back feeling stronger,” she revealed, adding that she is now on steroids and other medications to stabilize her condition. “I’m doing everything I can to get back to feeling like I can do this.”

She added, “I’ve never once felt this way until recently. And it’s heartbreaking.”

A Long Battle with Skin Cancer

Teddi Mellencamp’s cancer journey began in October 2022 when she was first diagnosed with skin cancer. Over the next year, she underwent multiple biopsies and surgeries, eventually revealing in early 2024 that the cancer had progressed to stage 4 and spread to her brain and lungs.

In February, she underwent emergency surgery to remove several brain tumors. But by April, new tumors had appeared. Despite these setbacks, Mellencamp kept her spirits high. She has also been regularly updating her fans with health progress, including the encouraging news just two months ago that her tumors were visibly shrinking.

“And then today I had the scan where they checked my lungs, and they are shrinking, and one of them has shrunk so much you can barely even see it,” she had shared at the time.

What Is Skin Cancer?

Skin cancer is the abnormal growth of skin cells, most often caused by overexposure to the sun’s ultraviolet (UV) rays. The most common types are basal cell carcinoma, squamous cell carcinoma, and melanoma—the most aggressive form, which can spread to other organs if not detected early.

While treatable in early stages, late-stage skin cancer that metastasizes (spreads to other parts of the body) becomes significantly harder to control. Treatments often include surgery, radiation, chemotherapy, and newer therapies like immunotherapy. Mellencamp’s cancer appears to be an advanced form, as it is in Stage IV and has spread to other parts of her body, requiring constant monitoring and multidisciplinary care.

Despite filing for divorce in November 2024, Edwin Arroyave, her husband has remained by Mellencamp’s side throughout her cancer treatment. “He’s had to step in and help me because I, some days, can’t do it,” she admitted during the podcast. “Nothing’s changed in that other than that [we’re] on hold because of what’s happening to me medically.”

For now, Mellencamp is focusing on recovery and regaining enough strength to resume treatment. “I can do all the things,” she said hopefully. “Just not today—but maybe soon.”